News and Events
Celebrating CCR Careers: Alan Rein, Ph.D.
Alan Rein, Ph.D., is a known expert in the field of viral assembly, particularly in retroviruses like the human immunodeficiency virus (HIV). After an extensive career studying molecular mechanisms of retroviral replication and pathogenesis, he has announced his retirement.
Read More
Clinical trial researches therapy for pancreatic acinar cell carcinoma (PACC)
A clinical trial led by Christine Campo Alewine, M.D. Ph.D., Lasker Clinical Research Scholar in the Laboratory of Molecular Biology, is researching a therapy for pancreatic acinar cell carcinoma (PACC), a rare type of pancreatic tumor.
Read More
Clinical trial researching therapy for aggressive blood cancers
A clinical trial led by Christopher J. Melani, M.D., Assistant Research Physician in the Lymphoid Malignancies Branch, is researching a combination drug therapy for aggressive blood cancers, such as non-Hodgkin lymphomas.
Read More
Clinical trial researches therapy for metastatic melanoma or renal cell carcinoma
A clinical trial led by Stephanie L. Goff, M.D., Associate Research Physician in the Surgery Branch, is researching a therapy for people with metastatic melanoma or renal cell carcinoma.
Read More
Clinical trial researches drug therapy for chronic graft-versus-host disease
A clinical trial led by Noa G. Holtzman, M.D., Assistant Research Physician in the Immune Deficiency Cellular Therapy Program, is researching a drug therapy for chronic graft-versus-host disease.
Read More
Clinical trial researches drug therapy for CNS tumors
A clinical trial led by Jing Wu, M.D., Ph.D., Lasker Clinical Research Scholar in the Neuro-Oncology Branch, is researching a drug therapy for aggressive diffuse gliomas.
Read More
2023 Frontiers in Basic Immunology
Dates: September 27-28, 2023
Location: Building 35, Room 610/620/630/640
The Center for Cancer Research at the National Cancer Institute is hosting a two-day national symposium on September 27-28, 2023 entitled 2023 Frontiers in Basic Immunology. The program includes recent advances in the field and should be an exciting forum for discussion and debate on the current understanding of basic immunological mechanisms. Check the website for a list of speakers.
Read More
With new database, NCATS data is poised to support development of precision cancer therapies
Data from thousands of compounds and nearly 200 cancer cell lines screened at the National Center for Advancing Translational Sciences are available through a new CellMiner database.
Read More
Andre Nussenzweig elected to the National Academy of Sciences
Andre Nussenzweig, Ph.D., Chief of the Laboratory of Genome Integrity, has been elected to the National Academy of Sciences in recognition of his distinguished and continuing achievements in original research. He investigates the mechanisms that maintain genomic stability and prevent cancer, particularly in DNA repair pathways.
Read More
Clinical trial researches drug therapy for prostate cancer
A clinical trial led by William Douglas Figg Sr., Pharm.D., Senior Investigator in the Genitourinary Malignancies Branch is researching a drug therapy for advanced prostate cancer.
Read More
In Memoriam: W. Michael Kuehl, M.D.
The CCR community is deeply saddened by the recent passing of W. Michael Kuehl, M.D., former Senior Investigator in the Genetics Branch.
Read More